OTLK
USDOutlook Therapeutics Inc. Common Stock
$1.190+0.020 (1.709%)
Real-time Price
Healthcare
Biotechnology
United States
Price Chart
Loading Chart...
Key Metrics
Market Metrics
Open
$1.170
High
$1.210
Low
$1.130
Volume
0.45M
Company Fundamentals
Market Cap
52.9M
Industry
Biotechnology
Country
United States
Trading Stats
Avg Volume
3.82M
Exchange
NCM
Currency
USD
52-Week Range
Low $0.79Current $1.190High $6.61
Related News
GlobeNewswire
Outlook Therapeutics Re-Submits Biologics License Application for ONS-5010
ISELIN, N.J., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (NASDAQ:OTLK), a biopharmaceutical company focused on optimizing the standard of care for bevacizumab for the treatment of retina diseases,
View more
Related Stocks
BILL
BILL Holdings Inc.
NASDAQ
EDP Services
PALI
Palisade Bio Inc.
NASDAQ
Biotechnology: ...
BANFP
BancFirst Corporation - BFC Capital Trust II Cumulative Trust Preferred Securities
NASDAQ
Major Banks
CRVS
Corvus Pharmaceuticals Inc.
NASDAQ
Biotechnology: ...
AUB
Atlantic Union Bankshares Corporation
NASDAQ
Major Banks
Stay Updated
Set price alerts, get AI analysis updates and real-time market news.